Sodium molybdate
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Sodium molybdate
- DrugBank Accession Number
- DB14496
- Background
Not Available
- Type
- Small Molecule
- Groups
- Approved, Experimental
- Structure
- Weight
- Average: 205.93
Monoisotopic: 207.864602 - Chemical Formula
- MoNa2O4
- Synonyms
- Anhydric sodium molybdate
- Molybdenum (as sodium)
- Sodium molybdate (anhydrous)
- Sodium molybdate(VI)
- Sodium molybdenum oxide
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Diagnostic agent Meckel diverticulum •••••••••••• ••••••••• Used in combination as diagnostic agent Meckel diverticulum Combination Product in combination with: Technetium Tc-99m pertechnetate (DB09314), Water (DB09145), Sodium chloride (DB09153) •••••••••••• ••••• •••••••• Diagnostic agent Salivary gland disorder •••••••••••• ••••••••• Diagnostic agent Sjögren's syndrome •••••••••••• ••••••••• Diagnostic agent Thyroid diseases •••••••••••• ••••••••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Sodium molybdate dihydrate 8F2SXI1704 10102-40-6 VXPCUCBABLNLFW-UHFFFAOYSA-L - Active Moieties
Name Kind UNII CAS InChI Key Molybdate ionic O0L10E6352 14259-85-9 MEFBJEMVZONFCJ-UHFFFAOYSA-N - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image ADDAMEL INFUSION N Sodium molybdate dihydrate (48.5 mcg) + Chromic chloride hexahydrate (53.3 mcg) + Cupric chloride dihydrate (3.4 mg) + Ferric chloride hexahydrate (5.4 mg) + Manganese chloride tetrahydrate (990 mcg) + Potassium Iodide (166 mcg) + Sodium selenite pentahydrate (105 mcg) + Sodium fluoride (2.1 mg) + Zinc chloride (13.6 mg) Solution, concentrate Intravenous FRESENIUS KABI COLOMBIA S.A.S. 2006-11-10 2009-05-08 Colombia ADDAMEL N Sodium molybdate dihydrate (4.85 mcg/ml) + Chromic chloride hexahydrate (5.33 mcg/ml) + Cupric chloride dihydrate (0.1 mg/ml) + Ferric chloride hexahydrate (0.54 mg/ml) + Manganese chloride tetrahydrate (19.8 mcg/ml) + Potassium Iodide (16.6 mcg/ml) + Sodium selenite (17.3 mcg/ml) + Sodium fluoride (0.21 mg/ml) + Zinc chloride (1.05 mg/ml) Injection, solution, concentrate Intravenous Fresenius Kabi Italia S.R.L. 2014-07-08 2020-05-12 Italy ADDAMEL N FOR INFUSION Sodium molybdate dihydrate (4.85 mcg/ml) + Chromic chloride hexahydrate (5.33 mcg/ml) + Cupric chloride dihydrate (0.34 mg/ml) + Ferric chloride hexahydrate (0.54 mg/ml) + Manganese chloride tetrahydrate (99 mcg/ml) + Potassium Iodide (16.6 mcg/ml) + Sodium selenite (6.9 mcg/ml) + Sodium fluoride (0.21 mg/ml) + Zinc chloride (1.36 mg/ml) Injection Intravenous FRESENIUS KABI (SINGAPORE) PTE LTD 1992-01-31 Not applicable Singapore ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION Sodium molybdate dihydrate (4.85 mcg/ml) + Chromic chloride hexahydrate (5.33 mcg/ml) + Cupric chloride dihydrate (102.3 mcg/ml) + Ferric chloride hexahydrate (540 mcg/ml) + Manganese chloride tetrahydrate (19.79 mcg/ml) + Potassium Iodide (16.6 mcg/ml) + Sodium selenite (17.29 mcg/ml) + Sodium fluoride (210 mcg/ml) + Zinc chloride (1050 mcg/ml) Solution Intravenous FRESENIUS KABI (SINGAPORE) PTE LTD 2017-07-24 Not applicable Singapore Addaven Konzentrat zur Herstellung einer Infusionslösung Sodium molybdate dihydrate (4.85 μg/ml) + Chromic chloride hexahydrate (5.33 μg/ml) + Cupric chloride dihydrate (0.1 mg/ml) + Ferric chloride hexahydrate (0.54 mg/ml) + Manganese chloride tetrahydrate (19.8 μg/ml) + Potassium Iodide (16.6 μg/ml) + Sodium selenite (17.3 μg/ml) + Sodium fluoride (0.21 mg/ml) + Zinc chloride (1.05 mg/ml) Injection, solution, concentrate Intravenous Fresenius Kabi Austria Gmb H 2015-03-02 Not applicable Austria - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Addamel N Sodium molybdate dihydrate (1.9 ug/1mL) + Chromic chloride hexahydrate (1 ug/1mL) + Cuprous chloride (0.13 mg/1mL) + Ferric chloride (0.11 mg/1mL) + Manganese chloride tetrahydrate (0.027 mg/1mL) + Potassium Iodide (0.013 mg/1mL) + Sodium selenite (3.2 ug/1mL) + Sodium fluoride (0.095 mg/1mL) + Zinc chloride (0.65 mg/1mL) Injection, solution Intravenous Fresenius Kabi USA, LLC 2013-05-07 2017-03-31 US ADDAMEL N 20 AMPUL Sodium molybdate (48.5 mcg/10mL) + Chromic chloride (53.3 mcg/10mL) + Cupric Chloride (3.4 mg/10mL) + Ferric chloride (5.4 mg/10mL) + Manganese chloride (990 mcg/10mL) + Potassium Iodide (166 mcg/10mL) + Sodium selenite (69 mcg/10mL) + Sodium fluoride (2.1 mg/10mL) + Zinc chloride (13.6 mg/10mL) Injection, solution Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2019-04-30 Not applicable Turkey ADDAVEN IV INFUZYON ICIN KONSANTRE SOLUSYON Sodium molybdate (48.5 mcg/10mL) + Chromic chloride (53.3 mcg/10mL) + Cupric Chloride (1.02 mg/10mL) + Ferric chloride (5.4 mg/10mL) + Manganese chloride (198 mcg/10mL) + Potassium Iodide (166 mcg/10mL) + Sodium selenite (173 mcg/10mL) + Sodium fluoride (2.1 mg/10mL) + Zinc chloride (10.5 mg/10mL) Injection, solution Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2016-09-06 2022-11-10 Turkey Tricare Prenatal 2-part Daily Prenatal Vitamin System Sodium molybdate (.0375 mg/1) + Ascorbic acid (30 mg/1) + Biotin (.150 mg/1) + Cholecalciferol (400 [iU]/1) + Chromium Cr-51 chloride (.060 mg/1) + Copper gluconate (1 mg/1) + Cyanocobalamin (.125 mg/1) + Doconexent (150 1/1) + Ferric pyrophosphate (4.5 mg/1) + Icosapent (37.5 1/1) + Levomefolic acid (1 mg/1) + Manganese citrate decahydrate (1 mg/1) + Nicotinamide (10 mg/1) + Omega-3 fatty acids (75 1/1) + Calcium pantothenate (5 mg/1) + Pyridoxine hydrochloride (2.5 mg/1) + Riboflavin (.85 mg/1) + Sodium selenite (.0325 mg/1) + Thiamine mononitrate (1.25 mg/1) + Zinc (7 mg/1) + alpha-Tocopherol succinate (15 [iU]/1) Kit Oral Medecor Pharma, Llc 2016-05-10 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 948QAQ08I1
- CAS number
- 7631-95-0
- InChI Key
- TVXXNOYZHKPKGW-UHFFFAOYSA-N
- InChI
- InChI=1S/Mo.2Na.4O/q;2*+1;;;2*-1
- IUPAC Name
- disodium dioxomolybdenumbis(olate)
- SMILES
- [Na+].[Na+].[O-][Mo]([O-])(=O)=O
References
- General References
- Not Available
- External Links
- KEGG Compound
- C15455
- ChemSpider
- 55350
- 36699
- ChEBI
- 75215
- Wikipedia
- Sodium_molybdate
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 1, 2 Completed Prevention Deficiency, Vitamin D / Pre-Eclampsia 1 Not Available Recruiting Not Available Long Haul COVID / Long-Haul COVID-19 / Post-Acute COVID-19 / Post-acute COVID-19 (PACS), or "Long COVID" Syndrome 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution, concentrate Intravenous Injection, solution Intravenous Injection, solution, concentrate Intravenous Injection Intravenous 5.33 mcg/ml Injection, solution Intravenous drip Solution Intravenous 5.33 mcg/ml Capsule Oral Powder Oral Tablet, film coated Solution Intravenous Solution Intravenous 50 GBq Liquid Oral Capsule, liquid filled Oral Solution Intravenous 0.053 mg/10ml Tablet Oral Injection, solution Parenteral Kit Oral Tablet, chewable Oral Capsule, liquid filled Oral 1 mg Solution Intraocular; Intravenous Capsule, gelatin coated Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -1.8 Chemaxon pKa (Strongest Acidic) -2.3 Chemaxon Physiological Charge -2 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 80.26 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 5.77 m3·mol-1 Chemaxon Polarizability 6.04 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at July 09, 2018 20:01 / Updated at October 06, 2020 04:50